Department of Gastroenterology, General Hospital of Northern Theater Command (formerly General Hospital of Shenyang Military Area), Shenyang, China.
Postgraduate College, Jinzhou Medical University, Jinzhou, China.
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):508-516. doi: 10.1002/jcsm.13154. Epub 2022 Dec 28.
Subcutaneous and visceral adipose tissues are important body components, but their effects on the mortality in patients with liver cirrhosis remain controversial based on the current evidence.
We retrospectively identified 372 eligible patients in whom subcutaneous adipose tissue index (SATI) and visceral adipose tissue index (VATI) could be measured by computed tomography images at the third lumbar vertebra. The association of SATI and VATI with the risk of death was evaluated on a continuous scale with restricted cubic spline curves based on Cox proportional hazards models. Cumulative probability of mortality was estimated by Nelson-Aalen cumulative risk curve analyses. Independent predictors of death were evaluated by competing risk analyses after adjusting for age, sex, and model for end-stage liver disease score.
Majority of patients were male (69.4%) with a mean age of 55.40 ± 10.68 years. SATI had a U-shaped association with mortality (P for non-linearity <0.001). Cutoff values of SATI were 19.7 and 51.8 cm /m at the points where hazard ratios were just <1.2. SATI was categorized as low (<19.7 cm /m ), moderate (19.7-51.8 cm /m ), and high (>51.8 cm /m ) level. There was no significant difference in the cumulative probability of mortality between low versus moderate SATI groups (Gray's test, P = 0.052) and high versus moderate SATI groups (Gray's test, P = 0.054). Competing risk analyses demonstrated that low SATI could increase the mortality compared with moderate SATI (subdistribution hazard ratio [sHR] = 1.66, 95% confidence interval [CI]: 0.992-2.78, P = 0.054) and was an independent predictor of death (sHR = 1.86, 95% CI: 1.059-3.28, P = 0.031). Competing risk analyses also demonstrated that high SATI could significantly increase the mortality compared with moderate SATI (sHR = 1.6, 95% CI: 1-2.54, P = 0.049), and was an independent predictor of death (sHR = 2.007, 95% CI: 1.195-3.37, P = 0.0085). VATI had an irregularly shaped association with mortality (P for non-linearity <0.001). Cutoff values of VATI were 9.8 and 40.2 cm /m at the points where hazard ratios were just <1.2. VATI was categorized as low (<9.8 cm /m ), moderate (9.8-40.2 cm /m ), and high (>40.2 cm /m ) level. There was no significant difference in the cumulative probability of mortality between low versus moderate VATI groups (Gray's test, P = 0.381) and high versus moderate VATI groups (Gray's test, P = 0.787). Competing risk analyses demonstrated that neither low (sHR = 1.27, 95% CI: 0.599-2.7, P = 0.53) nor high VATI (sHR = 0.848, 95% CI: 0.539-1.34, P = 0.48) was an independent predictor of death compared with moderate VATI.
Both excessive deficiency and accumulation of subcutaneous adipose tissues negatively influence the outcomes of cirrhotic patients.
皮下和内脏脂肪组织是重要的身体组成部分,但基于现有证据,它们对肝硬化患者死亡率的影响仍存在争议。
我们回顾性地在第三腰椎的计算机断层扫描图像中测量了 372 名符合条件的患者的皮下脂肪组织指数 (SATI) 和内脏脂肪组织指数 (VATI)。基于 Cox 比例风险模型,使用限制性立方样条曲线对 SATI 和 VATI 与死亡风险的关联进行了连续尺度的评估。通过 Nelson-Aalen 累积风险曲线分析估计死亡率的累积概率。在调整年龄、性别和终末期肝病模型评分后,通过竞争风险分析评估死亡的独立预测因素。
大多数患者为男性 (69.4%),平均年龄为 55.40±10.68 岁。SATI 与死亡率呈 U 形关联 (非线性 P<0.001)。危险比刚小于 1.2 时,SATI 的截断值为 19.7 和 51.8 cm/m。SATI 分为低 (<19.7 cm/m)、中 (19.7-51.8 cm/m) 和高 (>51.8 cm/m) 水平。低 SATI 组与中 SATI 组 (Gray 检验,P=0.052) 和高 SATI 组与中 SATI 组 (Gray 检验,P=0.054) 的死亡率累积概率无显著差异。竞争风险分析表明,与中 SATI 相比,低 SATI 可增加死亡率 (亚分布危险比 [sHR] =1.66,95%置信区间 [CI]:0.992-2.78,P=0.054),是死亡的独立预测因素 (sHR=1.86,95%CI:1.059-3.28,P=0.031)。竞争风险分析还表明,与中 SATI 相比,高 SATI 可显著增加死亡率 (sHR=1.6,95%CI:1-2.54,P=0.049),是死亡的独立预测因素 (sHR=2.007,95%CI:1.195-3.37,P=0.0085)。VATI 与死亡率呈不规则形状的关联 (非线性 P<0.001)。危险比刚小于 1.2 时,VATI 的截断值为 9.8 和 40.2 cm/m。VATI 分为低 (<9.8 cm/m)、中 (9.8-40.2 cm/m) 和高 (>40.2 cm/m) 水平。低 VATI 组与中 VATI 组 (Gray 检验,P=0.381) 和高 VATI 组与中 VATI 组 (Gray 检验,P=0.787) 的死亡率累积概率无显著差异。竞争风险分析表明,低 (sHR=1.27,95%CI:0.599-2.7,P=0.53) 和高 VATI (sHR=0.848,95%CI:0.539-1.34,P=0.48) 均不是与中 VATI 相比死亡的独立预测因素。
皮下脂肪组织过度缺乏和积累都对肝硬化患者的预后产生负面影响。